Wenbo Ma, Chang Han, Jinqiang Zhang, Kyoungsub Song, Weina Chen, Hyunjoo Kwon, Tong Wu – 28 January 2020
Lisa C. Casey, Robert J. Fontana, Ariel Aday, David B. Nelson, Jody A. Rule, Michelle Gottfried, Minh Tran, William M. Lee, for the Acute Liver Failure Study Group – 28 January 2020
Hye Won Lee, Grace Lai‐Hung Wong, Raymond Kwok, Kai Chow Choi, Carmen Ka‐Man Chan, Sally She‐Ting Shu, Julie Ka‐Yu Leung, Angel Mei‐Ling Chim, Andrea On‐Yan Luk, Ronald Ching‐Wan Ma, Henry Lik‐Yuen Chan, Juliana Chung‐Ngor Chan, Alice Pik‐Shan Kong, Vincent Wai‐Sun Wong – 28 January 2020
Oren K. Fix – 27 January 2020
Jules L. Dienstag – 23 January 2020
Lilly Kristin Kunzmann, Tanja Schoknecht, Tobias Poch, Lara Henze, Stephanie Stein, Marvin Kriz, Ilka Grewe, Max Preti, Johannes Hartl, Nadine Pannicke, Moritz Peiseler, Marcial Sebode, Roman Zenouzi, Thomas Horvatits, Marius Böttcher, Britt‐Sabina Petersen, Christina Weiler‐Normann, Leonard U. Hess, Annika Elise Ahrenstorf, Sebastian Lunemann, Gloria Martrus, Lutz Fischer, Jun Li, Antonella Carambia, Johannes Kluwe, Samuel Huber, Ansgar W. Lohse, Andre Franke, Johannes Herkel, Christoph Schramm, Dorothee Schwinge – 23 January 2020
Narendra S. Choudhary, Swapnil Dhampalwar, Rajesh Puri – 23 January 2020
David Wallace, Thomas Cowling, Mark J. McPhail, Sarah E. Brown, Varuna Aluvihare, Abid Suddle, Georg Auzinger, Michael A. Heneghan, Ian A. Rowe, Kate Walker, Nigel Heaton, Jan Meulen, William Bernal – 22 January 2020
Neil Mehta – 22 January 2020 – Deciding on specific treatment strategies involves not only tumor stage, performance status, and severity of underlying liver disease, but additional factors such as biomarkers, organ availability, and radiographic tumor response to treatment. In this review, we present hepatocellular carcinoma (HCC) cases to highlight how to determine therapeutic options for HCC in specific scenarios, including resection versus liver transplant, choice of initial local regional treatment, tumor downstaging, and systemic therapies for advanced HCC.
Binita M. Kamath, Wen Ye, Nathan P. Goodrich, Kathleen M. Loomes, Rene Romero, James E. Heubi, Daniel H. Leung, Nancy B. Spinner, David A. Piccoli, Estella M. Alonso, Stephen L. Guthery, Saul J. Karpen, Cara L. Mack, Jean P. Molleston, Karen F. Murray, Philip Rosenthal, James E. Squires, Jeffrey Teckman, Kasper S. Wang, Richard Thompson, John C. Magee, Ronald J. Sokol, for the Childhood Liver Disease Research Network (ChiLDReN) – 22 January 2020 – Alagille syndrome (ALGS) is an autosomal dominant multisystem disorder with cholestasis as a defining clinical feature.